We aimed to construct a novel atherosclerosis model for studying the pathological and physiological mechanism of the development of atherosclerotic plaques by introducing a fibrillin-1 heterozygous mutation into LDLR−/− mice via homologous recombination. The gene discussed is LDLR; the disease is atherosclerosis.